Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorUniversity of Vienna

About this trial

Shift work is a well-known risk factor for the development of overweight and obesity, which may lead to downstream effects such as increased risk of cardiometabolic diseases and cancer. However, the biological and behavioral mechanisms underlying the obesogenicity of night shift work are not well understood. Population-based mechanistic studies in real life shift workers are needed to address how night shift work impacts metabolic health.

The investigators aim to characterize the behavioural, environmental, and biological mechanisms and pathways for the association of night shift work and obesity across Europe.

The investigators will conduct a cross sectional study in 5 European countries (Austria, Denmark, Germany, Netherlands and Poland) and recruit 1000 rotating night shift workers and day workers (200/country) from the health sector and different industries. Night and day workers will be age-frequency (3 age groups), gender and (where possible) working tasks matched. Participants will complete online questionnaires and report their diet habits in a mobile app. Body composition, dietary behavior and sensory preferences will be tested. Biologic specimens (blood, urine, saliva, hair and feces) will be collected at the workplace on a day where participants are working on a day shift (or a day off). In a subsample (Austria and Netherlands) shift workers will provide biological samples (spot blood, urine and saliva) both on a day shift and on a night shift. Biomarkers including hormones, cellular immunity and inflammation, parameters linked to gut health and metabolism of fat and sugar, appetite, oxidative stress, metabolomics and microbiota will be measured. The investigators hypothesize that compared to day workers, night shift workers will experience disrupted levels of pre-obesity markers. Higher circadian disruption, sleep disruption and mistimed eating patterns workers will be associated with more disrupted biomarker profiles. Among rotating shift workers, night shift will be associated with acute disrupted melatonin production, metabolomic profiles and composition of oral microbiota compared to a day shift.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Health care sector or industrial shift worker

Employed or self-employed

21 years or older

≥ 24 h/ week

Disqualifiers

Pregnancy

Lactation period

BMI of 40 kg/m2 or above

Present treatment of a disease e.g. cancer radio- or chemotherapy

Trial population

We are recruiting shift worker and day worker in the industrial and healthcare setting.

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • No intervention

    Other intervention

    No intervention

Treatment groups

1,000 Participants
are divided into 2 treatment groups
Group A: Nightshift workers1 intervention
Group B: Dayshift workers1 intervention

Trial outcomes

Primary outcomes

1

high-sensitive C-Reactive Protein (hs-CRP)

Compare hs-CRP levels between night shift workers and day shift workers

Time frame
Baseline

Secondary outcomes

1

The investigators will consider levels of hormones in plasma

Compare melatonin levels between night shift workers and day shift workers

Time frame
Baseline
2

The investigators will consider levels of hormones in plasma

Compare cortisol levels between night shift workers and day shift workers

Time frame
Baseline
3

The investigators will consider levels of parameters linked to gut health in serum and in feces

Compare Short-chain fatty acids (SCFA) levels between night shift workers and day shift workers

Time frame
Baseline
4

The investigators will consider levels of parameters linked to gut health in serum and in feces

Compare Fatty acid-binding protein (FABP) levels between night shift workers and day shift workers

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Vienna

Lead sponsor

Medical University of Vienna

Collaborator

FH Joanneum Gesellschaft mbH

Collaborator

Wageningen University and Research

Collaborator

Wageningen University

Collaborator

University of Bremen

Collaborator

Verein zur Förderung des Technologietransfers an der Hochschule Bremerhaven e.V.

Collaborator

UNIVERSYTET MEDYCZNY W LODZI

Collaborator

Københavns Universitet

Collaborator

Charite University, Berlin, Germany

Collaborator

Erasmus Medical Center

Collaborator